Clinical Trial

Local Antibiotic Delivery for Community Acquired Pneumonia

Study acronym: LANDCAP-1
Not Yet Recruiting Phase 2/3
View on ClinicalTrials.gov →
Record status
This record was last updated March 10, 2025 (before its estimated September 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
A randomized, double-blinded clinical pilot study to assess whether addition of inhaled levofloxacin 240 mg twice daily for three days leads to improved or worsened physiological status in CAP patients with and without pre-existing lung disease.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-02-28.
Trial Details
NCT Number NCT06859450
Lead Sponsor Copenhagen Respiratory Research
Conditions Community Acquired Pneumonia (CAP)
Enrollment 36 participants
Start Date 2025-03-04
Primary Completion 2025-09-01 (estimated)
Study Completion 2028-09-01 (estimated)
Updated on ClinicalTrials.gov 2025-03-10